SCHEMBL4670028

SCHEMBL4670028

CC(=O)C(N)(CCCNC(N)=O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.33
PAOX Q6QHF9 2/20 0.32
ADRA1A P35348 1/20 0.32
ARG1 P05089 1/20 0.31
KDM4C Q9H3R0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL766428 0.86 ALOX15 (0.36) KDM4EMAPK1HIF1APAOXADRA1A
SCHEMBL20524307 0.86 ALOX15 (0.36) KDM4EMAPK1HIF1APAOXADRA1A
SCHEMBL6474944 0.83 MEN1 (0.34) KDM4C
SCHEMBL2113655 0.81 ODC1 (0.30)
SCHEMBL2115692 0.80 ARG1 (0.32) ARG1
SCHEMBL3818712 0.80 ARG1 (0.32) ARG1
SCHEMBL31031980 0.79 MAOA (0.39)
SCHEMBL1504428 0.78 ARG1 (0.50) KDM4EMAPK1HIF1APAOXADRA1A
SCHEMBL20978268 0.78 ARG1 (0.50) KDM4EMAPK1HIF1APAOXADRA1A
SCHEMBL1455221 0.78 ARG1 (0.50) KDM4EMAPK1HIF1APAOXADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240117357-A1 REGULATION OF METABOLISM AND OBESITY BY MITOCHONDRIAL MUL1 E3 UBIQUITIN LIGASE UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2024-04-11 US disclosed
US-11946092-B2 Method for producing 2-keto-3-deoxygluconate from 2-(acetylamino)-2-deoxy-d-gluconic acid by two enzymes SHANDONG UNIVERSITY (CN) 2024-04-02 US disclosed
US-20230323409-A1 Method for producing 2-keto-3-deoxygluconate from 2-(acetylamino)-2-deoxy-D-gluconic acid by two enzymes SHANDONG UNIVERSITY (CN) 2023-10-12 US disclosed
US-10267777-B2 Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment METABOLON, INC. (US) 2019-04-23 US disclosed
US-20180320233-A1 GENOMICS-BASED, TECHNOLOGY-DRIVEN MEDICINE PLATFORMS, SYSTEMS, MEDIA, AND METHODS HUMAN LONGEVITY, INC. 2018-11-08 US disclosed
US-20170089872-A1 SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT METABOLON, INC. 2017-03-30 US disclosed
EP-3129909-A1 SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT Metabolon, Inc. (US) 2017-02-15 EP disclosed
WO-2015157407-A1 SMALL MOLECULE BIOCHEMICAL PROFILING OF INDIVIDUAL SUBJECTS FOR DISEASE DIAGNOSIS AND HEALTH ASSESSMENT METABOLON, INC. (US) 2015-10-15 WO disclosed
WO-2014027702-A1 METHOD FOR PRODUCING L-ARGININE USING BACTERIUM OF THE FAMILY ENTEROBACTERIACEAE HAVING N-ACETYLORNITHINE DEACETYLASE WITH DOWNREGULATED ACTIVITY AJINOMOTO CO.,INC. (JP) 2014-02-20 WO disclosed
EP-1948248-A2 MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY MEANS AND METHODS THEREOF Katz-Brull, Rachel (IL) 2008-07-30 EP disclosed
WO-2007052274-A2 MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY MEANS AND METHODS THEREOF BRAIN WATCH LTD. (IL) 2007-05-10 WO disclosed